Webull offers ADMP stock news, real time Adamis Pharma news help you invest smart. iso4217:USD xbrli:shares UNITED STATES SECURITIES AND... Allergy Immunotherapy Market Size, Share, Industry, Analysis, Growth, Report 2020-2027. View Adamis Pharmaceuticals Corporation ADMP investment & stock information. Adamis Pharma (NASDAQ:ADMP) stock is taking off on Friday after a week of positive news for the company. Historical and current end-of-day data provided by FACTSET. The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. ️ Join our groups below!Discord: https://discord.gg/cySrUGHmTelegram: https://t.me/moneytalkgram Grow your Wallet with M1 Finance. Sign Up. Feb 22, 2021 (Heraldkeepers) -- Post-Market 0.01 (1.08%) Please ensure that you fully understand the risks involved before trading. View live ADAMIS PHARMACEUTICALS CORPORATION chart to track its stock's price action. Subscriber Agreement & Terms of Use, SAN DIEGO , Feb. 02, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), today announced the closing of its underwritten public offering of 46,621,621 shares of its common stock, including 6,081,081 shares sold pursuant to the exercise in full of the underwriters' option to - Patent Eagle, http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=1&p=1&f=G&l=50&d=PTXT&S1=(20210216.PD.+AND+adamis)&OS=ISD/02/16/2021+AND+adamis. Investors should consider their investment objectives and risks carefully before investing. Create a list of the investments you want to track. DOW 0.00%. 10,919,011 today by the US Patent and Trademark Office, titled: POWDER MIXING APPARATUS AND METHOD OF USE.' 0000887247 false 0000887247 2021-03-02 2021-03-02 iso4217:USD xbrli:shares The stock has an overall rating of Underweight and investors could take advantage and scoop up stock of the company. Get the latest news and real-time alerts from Adamis Pharmaceuticals Corporation (ADMP) stock at Seeking Alpha. Feb 24, 2021 (Penny Stocks via COMTEX) -- Feb 22, 2021 (Market Insight Reports) -- ADMP--0.00%--8 … Feb 22, 2021 (The Expresswire) -- ADMP | Complete Adamis Pharmaceuticals Corp. stock news by MarketWatch. The past performance of a security, or financial product does not guarantee future results or returns. Intraday data delayed at least 15 minutes or per exchange requirements. Adamis Pharmaceuticals Corporation Common Stock (ADMP) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The Global Allergy Immunotherapy Market is estimated to value over USD 3.1 billion by 2027 end with a CAGR of over... Respiratory Devices Market Insights 2021 With Regional Overview, Investment Opportunities, Share, Gross Margin, Top Key Players, Supply Demand Scenario, Pricing Analysis and Forecast to 2026, Agriculture IoT Market Research Report by Component, by Agriculture Type, by Application - Global Forecast to 2025 - Cumulative Impact of COVID-19, Adamis Pharma Stock Down Despite US Patent Covering Naloxone, Adamis strengthens patent portfolio for ZIMHI opioid overdose treatment, Adamis Pharmaceuticals ([[ADMP]] +1.3%) announces that it has recently received a notice that one of its patent applications relating to its ZIMHI high dose naloxone injection product candidate, intended for the, Adamis Pharmaceuticals Says Received Notice That One Patent Application Relating To ZIMHI Was Allowed By U.S. Patent And Trademark Office, SAN DIEGO, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ("Company") today announced that it recently received a notice that one of its patent applications, Adamis Pharmaceuticals Strengthens Patent Portfolio for Its Naloxone Product Candidate, 'PATENT $ADMP Adamis Pharmaceuticals issued US Patent No. ADMP Stock: 4 Things to Know About Adamis Pharma Today as Shares Rocket Again. News. The company's shares closed last Monday at $1.35. Investors should be aware that system response, execution price, speed, liquidity, market data, and account access times are affected by many factors, including market volatility, size and type of order, market conditions, system performance, and other factors. ADMP Stock: Adamis Is Climbing on SYMJEPI News - CNA Finance. SAN DIEGO, Jan. 28, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in various therapeutic areas, including allergy, opioid overdose, respiratory and inflammatory disease, announced today that it intends to offer to sell shares of its common stock in an underwritten public offering. Adamis Pharmaceuticals (ADMP) Surges: Stock Moves 6.7% Higher Adamis Pharmaceuticals (ADMP) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes. Our clearing firm Apex Clearing Corp has purchased an additional insurance policy. (EDGAR Online via COMTEX) -- The coverage limits provide protection for securities and cash up to an aggregate of $150 million, subject to maximum limits of $37.5 million for any one customer’s securities and $900,000 for any one customer’s cash. Free trading of stocks, ETFs and options refers to $0 commissions for Webull Financial LLC self-directed individual cash or margin brokerage accounts and IRAs that trade U.S. listed securities via mobile devices, desktop or website products. When someone says the words "penny stocks," what comes to... Best Penny Stocks For Your February 2021 Watch List? Find the latest Adamis Pharmaceuticals Corporat (ADMP) stock quote, history, news and other vital information to help you with your stock trading and investing. View real-time stock prices and stock quotes for a full financial overview. LOG IN. The company is seeking to test out its Tempol for treating patients affected by the virus. What You Should Know, New Strong Sell Stocks for September 16th, Adamis Pharmaceuticals (ADMP) Reports Q2 Loss, Misses Revenue Estimates, Adamis Pharmaceuticals (ADMP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release. ADMP 0.92 0.04 (4.03%). iso4217:USD xbrli:shares UNITED STATES SECURITIES AND... Webull provides a variety of real-time ADMP stock news. Something went wrong while loading Watchlist. Feb 24, 2021 (Penny Stocks via COMTEX) -- Copyright © 2021 MarketWatch, Inc. All rights reserved. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Relevant regulatory and exchange fees may apply. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stock analysis for Adamis Pharmaceuticals Corp (ADMP:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. ADMP stock was sold by a variety of institutional investors in the last quarter, including Verdence Capital Advisors LLC. ADMP Adamis Pharmaceuticals Corporation Current Report Filing (8-k) Item 1.01 Entry into a Material Definitive Agreement. Please refer to our Fee Schedule for more details. NASDAQ 0.00%. Rooms Shows Rankings Earnings Calendar Shop. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. According to 360 Research Reports, the “Epinephrine Auto-Injector Market" 2021 by Types (0.15mg epinephrine auto injector,... Allergic Rhinitis Drugs Market Research With Method, Top Companies, Global Development Factors,and Forecast 2026. HOME MARKET TRADE PRICING DOWNLOAD HELP. The Company is engaged in the development of its specialty pharmaceutical products. By using this site you agree to the Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development and sales of pharmaceutical, specialty biopharmaceutical and other drug products. There is always the potential of losing money when you invest in securities, or other financial products. It considers technical and fundamental factors and is a good starting point for evaluating a stock. ADMP Stock: 4 Things to Know About Adamis Pharma Today as Shares Rocket Again. ADMP Stock Summary. The company was founded in June 2006 and is headquartered in San Diego, CA. Adamis Pharma (NASDAQ:ADMP) stock is taking off on Friday after a week of positive news for the company. The value of securities may fluctuate and as a result, clients may lose more than their original investment. Are These Cheap Penny Stocks On Your "Buy" List Today? Please read Characteristics and Risks of Standardized Options before investing in options. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. You can receive the latest news about Adamis Pharma through multiple platforms. Adamis Pharmaceuticals Corporation (ADMP), today announced the closing of its underwritten public offering of 46,621,621 shares of its common stock, including 6,081,081 shares sold pursuant to the exercise in full of the underwriters' option to purchase additional shares, … Who this matters to: Overall Ranking is a comprehensive evaluation. No content on the Webull Financial LLC website shall be considered as a recommendation or solicitation for the purchase or sale of securities, options or other investment products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology. Zacks Equity Research 01/08/2021 02:30 AM ET 0000887247 false 0000887247 2021-02-09 2021-02-09 iso4217:USD xbrli:shares Cookie Notice (). The volatility of Adamis Pharmaceuticals Corp's share price is greater than that of 86.47% US stocks with at least 200 days of trading history. According to, Adamis gets FDA greenlight for tempol human studies in COVID-19, Adamis Pharmaceuticals ([[ADMP]] +5.1%) announces that the U.S. FDA has given it the go ahead for the Investigational New Drug ((IND)) application and proposed clinical trial of Tempol for the, DJ Adamis Pharmaceuticals Shares Rise 10% After FDA Completes Safety Review, Adampis Pharmaceuticals Says Cleared To Proceed With Human Studies Of Tempol For Treatment Of COVID-19, Adamis Pharmaceuticals Cleared to Proceed with Human Studies of Tempol for the Treatment of COVID-19 SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) --  Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), Adamis Pharmaceuticals Cleared to Proceed with Human Studies of Tempol for the Treatment of COVID-19. Real time Adamis Pharmaceuticals (ADMP) stock price quote, stock graph, news & analysis. Trending now. Log In. This information may help you make smarter investment decisions. Jobless claims fall sharply to lowest level since November, General Electric stock price target raised to $14 from $13 at Deutsche Bank, Qualtrics stock price target cut to $41 from $56 at Deutsche Bank, United Natural Foods stock price target raised to $33 from $20 at Deutsche Bank, Vivint Smart Home upgraded to buy from hold at Deutsche Bank, ADT upgraded to buy from hold at Deutsche Bank, Camping World Holdings upgrade to outperform from market perform at BMO Capital, Oracle stock price target raised to $93 from $82 at Monness Crespi Hardt, Central Pacific Financial upgraded to outperform from market perform at Raymond James, Lagarde: Biden stimulus plan will have impact on eurozone growth, Adamis Pharmaceuticals downgraded to hold from buy at Maxim Group, Adamis Pharmaceuticals downgraded to neutral at Dawson James, Adamis Pharma downgraded to market perform vs. outperform at Raymond James, Adamis Pharmaceuticals downgraded to sell from neutral at B. Riley FBR, Adamis Pharmaceuticals stock price target cut to $6 from $10 at Maxim Group, Adamis Pharmaceuticals started at buy with $5 stock price target at Dawson James, Adamis Pharmaceuticals stock price target cut to $6.70 from $8.50 at Raymond James, Makers of EpiPen and rival products have shares drop after Teva appproval, Teva stock surges 7% after FDA approves first rival generic EpiPen, Adamis Pharmaceuticals stock price target raised to $8.50 from $6.40 at Raymond James, Adamis shares tumble after letter from FDA, Adamis Pharma stock jumps after FDA agrees to review injectable opioid-overdose treatment, Adamis stock surges on release of EpiPen alternative, Generic EpiPen may not launch in time for allergic kids going back to school, Teva’s generic EpiPen approved in the U.S., with perfect timing, FDA approves first rival generic EpiPen, sending Teva shares up 6%, Adamis has a partner to market its EpiPen competitor after a year-long search, Novartis buys U.S. rights to EpiPen rival, Stocks close higher as technology shares rally, Adamis's stock soars after commercialization partnership for EpiPen competitor announced, Adamis Pharma (ADMP) Receives a Hold from Raymond James, Adamis Pharma (ADMP) Gets a Hold Rating from Raymond James, Raymond James Sticks to Its Hold Rating for Adamis Pharma (ADMP), Analysts Offer Insights on Healthcare Companies: Adamis Pharma (ADMP) and Johnson & Johnson (JNJ), FLDM Stock Alert: Why Fluidigm Shares Are Shooting Higher Today, ADMP Stock: 4 Things to Know About Adamis Pharma Today as Shares Rocket Again, Adamis’ COVID-19 Treatment Has Potential, but the Stock Is Still Not a Buy: Analyst, Adamis (ADMP) Submits Tempol IND for COVID-19, Shares Soar, ADMP Stock Alert: The Covid-19 Treatment News That Has Adamis Pharma Shares Soaring Today, Adamis Pharmaceuticals (ADMP) Surges: Stock Moves 6.7% Higher, Biotech Stock Roundup: MRNA's Progress With Coronavirus Vaccine, News From BMY, ALKS, Adamis Pharmaceuticals (ADMP) Reports Q3 Loss, Misses Revenue Estimates, Will Adamis Pharmaceuticals (ADMP) Report Negative Q3 Earnings? ADMP Adamis Pharmaceuticals Corporation Current Report Filing (8-k) Item 1.01 Entry into a Material Definitive Agreement. Higher-dose naloxone injection hoped to counter rising opioid abuse. There are currently no items in this Watchlist. SAN DIEGO, Feb 22, 2021 (GLOBE NEWSWIRE via COMTEX) -- Cryptocurrency trading is offered through an account with Apex Crypto. Webull Financial LLC is a member of the Financial Industry Regulatory Authority (FINRA), Securities Investor Protection Corporation (SIPC), The New York Stock Exchange (NYSE), NASDAQ and Cboe EDGX Exchange, Inc (CBOE EDGX). Options involve risks and are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses. For ADMP, its debt to operating expenses ratio is greater than that reported by merely 13.96% of US equities we're observing. © 2021 Webull Financial LLC, All rights reserved. S&P 500 0.00%. All investments involve risks and is not suitable for every investor. 5 Names To Know. 01-22 cnafinance.com - 1 - Adamis Pharmaceuticals Corp (NASDAQ: ADMP) is screaming for the top in the market this morning, after the company announced that its epinephrine injection product is now available to members of the Walgreens Prescription Savings Club. Source: Bukhta Yurii / Shutterstock.com Here’s what investors need to know about ADMP stock rising today. ADMP rank of 20 means that it ranks below 80% of stocks. Options trading privileges subject to Webull Financial LLC review and approval. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends. #ADMP. 5 Penny Stocks to Watch in February 2021 As we enter the second week of February, the time to find top penny stocks... Adamis Pharma (ADMP) Receives a Hold from Raymond James, Raymond James analyst Elliot Wilbur maintained a Hold rating on Adamis Pharma (ADMP) today. Apex Crypto is not a registered broker-dealer or FINRA member and your cryptocurrency holdings are not FDIC or SIPC insured. Visit a quote page and your recently viewed tickers will be displayed here. Adamis Pharmaceuticals Corporation NASDAQ Updated Mar 8, 2021 10:23 PM. Webull Financial LLC is a member of SIPC, which protects securities customers of its members up to $500,000 (including $250,000 for claims for cash). A high-level overview of Adamis Pharmaceuticals Corporation (ADMP) stock. This browser is no longer supported at MarketWatch. Intraday Data provided by FACTSET and subject to terms of use. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. Securities trading is offered to self-directed customers by Webull Financial LLC, a broker dealer registered with the Securities and Exchange Commission (SEC). Get the latest Adamis Pharmaceuticals Corporat (ADMP) stock news and headlines to help you in your trading and investment decisions. Cancel. For the best MarketWatch.com experience, please update to a modern browser. To see how Adamis Pharmaceuticals Corporation stock has been performing today in comparison to its peers in the industry, here are the numbers: ADMP stock’s performance was -3.55% at last check in today’s session, and +66.64% in the past year, while Zoetis Inc Cl A (ZTS) has been trading +2.34% in recent session and positioned +15.92% higher than it was a year ago. SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (Nasdaq: ADMP)... Epinephrine Auto-Injector Market 2021 : Latest Industry Trends, Growth, Share, Size and 2026 Forecast Research Report with Top countries Data. Get the latest Adamis Pharmaceuticals Corporation ADMP detailed stock quotes, stock … Is the Options Market Predicting a Spike in Adamis Pharmaceuticals (ADMP) Stock. Find the latest news headlines from Adamis Pharmaceuticals Corporation Common Stock (ADMP) at Nasdaq.com. It offers Symjepi product for allergy, respiratory, opioid overdose, and erectile dysfunction (ED), markets. Explanatory brochure available upon request or at www.sipc.org. Log in to see them here or sign up to get started. All quotes are in local exchange time. ADMP stock was also up earlier this week on treatment news for the novel coronavirus. Japan, Japan, Thu, 25 Feb 2021 04:21:06 / Comserve Inc. / -- Competitive Analysis: ASIT Biotech, Circassia, Mylan N.V., Adamis Pharmaceuticals Corporation,... 4 Cheap Penny Stocks To Buy For Under $5 Before March 2021. Find market predictions, ADMP financials and market news. The scope also covers competitive overview... Allergy Immunotherapy Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast 2020 to 2027. (EDGAR Online via COMTEX) -- Company insiders that have sold Adamis Pharmaceuticals company stock in the last year include David J Marguglio, Dennis J Phd Carlo, Karen K Daniels, Robert O Hopkins, and Ronald B Moss. Find the latest Adamis Pharmaceuticals Corporat (ADMP) stock quote, history, news and other vital information to help you with your stock trading and investing. Privacy Notice, and Similar to SIPC protection, this additional insurance does not protect against a loss in the market value of securities. Get the latest Adamis Pharmaceuticals Corp (ADMP) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Member, Characteristics and Risks of Standardized Options. Get Adamis Pharmaceuticals Corp (ADMP:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. The report covers analysis on regional and country level market dynamics. SIGN UP. Adamis Pharmaceuticals Corporation is a pharmaceutical company. Stocktwits is the largest social network for finance. Have Watchlists? Looking further, we note that the PEG ratio for the ADMP stock currently stands at 0, and the most recent price level today is 33.9% off its SMA20 and 101.05% from its 50-day simple moving average.